Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.59
-0.11 (-1.26%)
Apr 29, 2026, 9:55 AM EDT - Market open
Kyverna Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -161.31 | -127.48 | -60.37 | -28.89 | -26.35 |
| Depreciation & Amortization | 1.8 | 2.13 | 1.71 | 1.05 | 0.59 |
| Loss (Gain) From Sale of Assets | 0.06 | - | - | - | 0.02 |
| Asset Writedown & Restructuring Costs | 0.65 | - | - | - | - |
| Loss (Gain) From Sale of Investments | -6.89 | -7.66 | -1.12 | -0.28 | - |
| Stock-Based Compensation | 10.08 | 8.36 | 2.22 | 0.93 | 0.25 |
| Other Operating Activities | 2.97 | 2.54 | 1.72 | 1.41 | 7.83 |
| Change in Accounts Payable | 0.54 | 0.74 | 4.08 | 0.68 | 0.01 |
| Change in Unearned Revenue | - | - | - | -7.03 | -5.66 |
| Change in Other Net Operating Assets | -1.62 | 7.12 | -0.66 | -3.98 | 1.16 |
| Operating Cash Flow | -153.71 | -114.25 | -52.41 | -36.11 | -22.16 |
| Capital Expenditures | -0.01 | -2.21 | -0.62 | -0.77 | -1.29 |
| Sale of Property, Plant & Equipment | 0.07 | - | - | - | - |
| Sale (Purchase) of Intangibles | -1.13 | - | - | - | - |
| Investment in Securities | 41.08 | -158.7 | -8.16 | -13.33 | - |
| Investing Cash Flow | 40.02 | -160.9 | -8.79 | -14.1 | -1.29 |
| Long-Term Debt Issued | 24.7 | - | - | - | - |
| Long-Term Debt Repaid | -0.81 | -0.96 | -0.78 | -0.25 | -0.04 |
| Net Debt Issued (Repaid) | 23.89 | -0.96 | -0.78 | -0.25 | -0.04 |
| Issuance of Common Stock | 117.9 | 341.43 | 0.65 | 0.18 | 0.03 |
| Repurchase of Common Stock | -0.14 | - | - | - | - |
| Other Financing Activities | -0.48 | -3.36 | -1.65 | - | - |
| Financing Cash Flow | 141.17 | 337.11 | 58.12 | 11.88 | 72.52 |
| Net Cash Flow | 27.47 | 61.96 | -3.08 | -38.33 | 49.08 |
| Free Cash Flow | -153.72 | -116.46 | -53.03 | -36.88 | -23.44 |
| Free Cash Flow Margin | - | - | - | -525.00% | -414.50% |
| Free Cash Flow Per Share | -3.47 | -3.04 | -78.72 | -80.97 | -88.17 |
| Cash Interest Paid | 0.42 | 0.14 | 0.19 | 0.07 | 0 |
| Levered Free Cash Flow | -92.08 | -68.46 | -29.74 | -23.54 | - |
| Unlevered Free Cash Flow | -91.77 | -68.37 | -29.63 | -23.5 | - |
| Change in Working Capital | -1.08 | 7.86 | 3.42 | -10.33 | -4.49 |
Source: S&P Capital IQ. Standard template.
Financial Sources.